More than 40% of medical students, residents, and practicing physicians report that fear of disclosing past mental health care or substance use treatment is a key reason they do not seek help [1].
The same logic runs through law firms and boardrooms. Addiction does not spare people with credentials, and the credentials themselves are often what turns a treatable medical condition into a secret.
Estimates suggest that 10 to 15% of healthcare professionals misuse substances at some point in their careers, and alcohol accounts for roughly half of physician substance use disorders (SUD) [2].
A national study of United States surgeons reported a 15.4% prevalence of alcohol abuse or dependence, more than double the 6.2% prevalence of Alcohol Use Disorder (AUD) recorded in the general adult population over a comparable period [2].
The legal profession shows a similar pattern. Among 2,863 licensed attorneys randomly sampled from the California Lawyers Association and the D.C. Bar, researchers documented high rates of depression, anxiety, stress, and risky or hazardous drinking. One in four women and roughly one in six men reported that they had considered leaving the profession over mental health concerns [3].
Executives are harder to count, because no licensing body tracks them and no national survey singles them out. What the data do show is that addiction is largely a working population’s problem. Of the roughly 46 million American adults who experienced a SUD in 2022, nearly two-thirds were employed [4].
Occupation matters within that group. Federal analysis of full-time workers found past-year SUD rates of 11.4% in the management industry against 9.5% across all full-time workers, placing management above the workforce average [5].
No. Success changes what addiction looks like rather than whether it develops. A workplace culture that rewards stoicism and treats stress endurance as a professional credential also normalizes inadequate self-care, which delays the point at which a problem becomes visible to anyone else [6]. Income, title, and competence buy time. They do not buy immunity.
Professionals face the same barriers everyone else does. Among adults with SUD who recognized they needed help, the most common reasons for avoiding treatment were [7]:
Those pressures land on top of obstacles specific to the profession, and each one reinforces the others. A 2025 review in the Journal of the American Medical Association identified a medical culture that stigmatizes mental health conditions, alongside real and perceived career consequences: increased scrutiny and inflexible schedules [6].
Underneath all of it sits a profound desire for confidentiality [6].
It postpones care. Licensing and credentialing applications have historically asked about any past diagnosis or treatment rather than about current fitness to practice, and questions of that kind are not a reliable indicator of whether someone can do the job today [1].
That is changing. The American Medical Association and allied organizations now recommend limiting these questions to current impairment, and the National Association of Medical Staff Services adopted that narrower standard in its updated 2024 credentialing guidance [1].
No. Federal data show that entering treatment is strongly associated with symptom severity, which means most people do not start care until the disorder has already advanced [7]. Waiting for a visible failure at work is what converts a private medical problem into a public one.
Addiction treatment records carry stronger federal privacy protection than most other medical records do. That extra layer exists for one reason: lawmakers recognized that people avoid care when they fear the information will follow them afterward [8].
Those protections were strengthened in recent years, and enforcement now sits with a federal civil rights office rather than resting on each program’s own discretion. Anyone who believes a program has mishandled their information can file a complaint directly [8].
Several professions operate structured programs built around referral, treatment, and monitoring [2]:
A 2026 comparative analysis found that FSPHP offers the most detailed guidance, HIMS uses a phased monitoring system tailored to aviation safety requirements, and CoLAP lacks specific return-to-work and monitoring guidelines. Structures also vary within each profession, because individual state programs function independently of one another [2].
Executives have no equivalent framework. There is no licensing board to report to and no monitoring program to enter, which removes one source of pressure and one source of structure at the same time.
Yes. Access to personal electronics is available to clients, generally following a 72-hour initial adjustment period (exceptions may be granted if needed), if working does not interfere with attendance and participation in programming. At Alta Mira Recovery, we recognize that many professionals cannot drop everything while they are with us.
For most participants, no. These frameworks are built around returning to practice rather than removal from it. Research on physicians monitored under PHPs reports high rates of program completion, return to licensed practice, and sustained recovery [2].
Alta Mira Recovery Programs works regularly with executives, physicians, attorneys, pilots, and other professionals for whom the stakes of seeking treatment feel particularly high. Privacy, discretion, and clinical rigor are built into how the program operates rather than arranged on request.
Care begins with medically supervised detox where physical dependence is present, continues through residential treatment, and moves into a continuing care program. Clinicians participate from the first day through an assessment process that integrates psychological, neuropsychological (as indicated), medical, and relational evaluations, so the treatment plan reflects the actual clinical picture rather than a standard sequence.
Alta Mira’s residential programming typically begins with a 30-day minimum commitment with some clients completing the full 90-day comprehensive program. The appropriate length depends on the clinical assessment, the presence of co-occurring mental health conditions, and what continuing care will look like afterward.
Alta Mira also offers a Detoxification and Assessment Service (DAS) with a baseline time frame of 10 days which can be adjusted on either side. This service is best for those who are unclear about either their diagnoses and/or whether to continue with residential or referral to an outpatient program. Detoxification is provided but not always necessary.
Yes. Alta Mira offers a free, confidential telephone consultation, and the admissions team can verify insurance benefits confidentially before any decision is made. Alta Mira is in-network with Kaiser Permanente and TriWest, and coverage under other plans can be verified directly.
For those seeking this level of specialized, integrated care in the San Francisco Bay Area, Alta Mira Recovery is a high-end, top-tier residential addiction center specializing in the treatment of substance use disorders and complex co-occurring mental health issues.
Our team of addiction treatment professionals provides sophisticated clinical care and diagnostic services, reflecting our appreciation for your unique qualities. If a career, a license, or a reputation is part of what has kept you silent, that is a reason to call rather than a reason to wait.
[1] American Medical Association. n.d. Issue Brief: Physician Health and Wellness. American Medical Association.
[2] Olufemi, M. O., et al. 2026, Mar. 15. A Comparative Analysis of Substance Use Disorder Programs Between Three Safety Sensitive Professions. Journal of Substance Use and Addiction Treatment, Article 209937.
[3] Anker, J., and Krill, P. R. 2021. Stress, Drink, Leave: An Examination of Gender-Specific Risk Factors for Mental Health Problems and Attrition Among Licensed Attorneys. PLOS ONE, 16(5), Article e0250563.
[4] Centers for Disease Control and Prevention. 2024, Jan. 11. Substance Use and Work. Centers for Disease Control and Prevention.
[5] Bush, D. M., and Lipari, R. N. 2015, Apr. 16. Substance Use and Substance Use Disorder by Industry. The CBHSQ Report. Substance Abuse and Mental Health Services Administration.
[6] Saddawi-Konefka, D., et al. 2025, Aug. 14. Reducing Barriers to Mental Health Care for Physicians: An Overview and Strategic Recommendations. JAMA.
[7] Choi, N. G., and Marti, C. N. 2025. Treatment Use Among U.S. Adults With a Substance Use Disorder: Associations With Symptom Severity, Problem Self-Perception, Comorbid Mental Illness, and Mental Health Treatment. International Journal of Environmental Research and Public Health, 22(4), Article 640.
[8] U.S. Department of Health and Human Services. n.d. Understanding Confidentiality of Substance Use Disorder (SUD) Patient Records or “Part 2”. U.S. Department of Health and Human Services.
